General MedicationsTOPICALGeneric
ACYCLOVIR
ACYCLOVIR
Standard Dose
5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ACYCLOVIR is listed in Drugs@FDA under application 212981 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ACYCLOVIR Form and strength CREAM;TOPICAL - 5% Sponsor CIPLA Submission history Latest submission status date: 2025-05-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview ACYCLOVIR is listed in Drugs@FDA under application 212981 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ACYCLOVIR Form and strength CREAM;TOPICAL - 5% Sponsor CIPLA Submission history Latest submission status date: 2025-05-02 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.